Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 57 out of 100. Digital health tools

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

The results were validated in an independent sample of 610 patients with Parkinson's disease from the National Institute of Neurological Disorders and Stroke Parkinson's Disease Biomarker Program (PDBP). Overall, patients starting in state 5 had the shortest time to terminal state (median 2·75 [95% CI 1·75-4·25] years).

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study of 423 participants. This study used machine learning to identify Parkinson's disease states and model progression, validated in 610 patients, with those starting in one state having the shortest time to a terminal state. This concerns Parkinson's disease progression and does not address treating, curing or preventing Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Severson, K. A., Chahine, L. M., Smolensky, L. A., Dhuliawala, M., Frasier, M., Ng, K., et al. (2021). Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning. The Lancet. Digital health. https://doi.org/10.1016/s2589-7500(21)00101-1

Vancouver

Severson KA, Chahine LM, Smolensky LA, Dhuliawala M, Frasier M, Ng K, et al. Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning. The Lancet. Digital health. 2021. doi:10.1016/s2589-7500(21)00101-1. PMID: 34334334.

BibTeX

@article{severson2021-34334334,
  author  = {Severson, K. A. and Chahine, L. M. and Smolensky, L. A. and Dhuliawala, M. and Frasier, M. and Ng, K. and Ghosh, S. and Hu, J.},
  title   = {{Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning}},
  journal = {The Lancet. Digital health},
  year    = {2021},
  doi     = {10.1016/s2589-7500(21)00101-1},
  pmid    = {34334334},
  url     = {https://doi.org/10.1016/s2589-7500(21)00101-1}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This study used machine learning to identify Parkinson's disease states and model progression, validated in 610 patients, with those starting in one state having the shortest time to a terminal state. This concerns Parkinson's disease progression and does not address treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 57/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 3 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 4 of 7; Citations per year 3 of 5; Impact for its field and year 3 of 6; Cited by studies here 1 of 6; Still being cited 3 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 57 of 100.57 of 100 points earned43 not earned

Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (The Lancet. Digital health)
Journal's citation record 1 / 4 The Lancet Digital Health: journal h-index 132 (OpenAlex, 2026-10-29)
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 3 / 5 2021 — within 6 year(s) of the newest study here
Sample size 2 / 4 423 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 4 / 7 Cited 90 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 12.9 citations a year over 7 year(s) since 2021
Impact for its field and year 3 / 6 Cited 5.4× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 3 / 4 Cited 64 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Jianying Hu: h-index 34 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Pittsburgh: institution h-index 1,470 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 4 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 34334334)
Free to read 0 / 2 Behind a paywall — scores zero
Total 57 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Digital health tools from nearby years

Also tagged “lewy”

1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Digital health tools

See all studies in Digital health tools →